Larvol Delta - ExpreS2ion-announces-completion-of-GLP-safety-study-for-ES2BC001-HER2VLP-breast-cancer-vaccine-candidate

ES2B-C001 - ExpreS2ion

https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-completion-of-glp-safety-study-for-es2b-c001--her2-vlp--breast-cancer-vaccine-c,c3962376

Apr 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next